Last update 08 May 2025

TQB2029

Overview

Basic Info

Drug Type
Bispecific T-cell Engager (BiTE)
Synonyms
Target
CD3 x GPRC5D
Action
stimulants, inhibitors
Mechanism
CD3 stimulants(T cell surface glycoprotein CD3 stimulants), GPRC5D inhibitors(G-protein coupled receptor family C group 5member D inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Multiple MyelomaRelapse multiple myeloma
Inactive Indication-
Originator Organization
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
Active Organization
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with TQB2029
NCT06700395
/ RecruitingPhase 1
Phase I Clinical Study Evaluating the Tolerability and Pharmacokinetics of TQB2029 for Injection in Subjects With Multiple Myeloma
CTR20244043
/ RecruitingPhase 1
评估注射用TQB2029在多发性骨髓瘤受试者中耐受性和药代动力学的I期临床研究
[Translation] A Phase I clinical study to evaluate the tolerability and pharmacokinetics of TQB2029 for injection in subjects with multiple myeloma
100 Clinical Results associated with TQB2029
Login to view more data
100 Translational Medicine associated with TQB2029
Login to view more data
100 Patents (Medical) associated with TQB2029
Login to view more data
100 Deals associated with TQB2029
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 1
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
28 Nov 2024
Relapse multiple myelomaPhase 1
China
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
13 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free